Mesenchymal stem cells in cancer: Tumor-associated fibroblasts and cell-based delivery vehicles

被引：144
|
作者：
Hall, Brett
Dembinski, Jennifer
Sasser, A. Kate
Studeny, Matus
Andreeff, Michael
Marini, Frank
机构：
[1] Univ Texas, MD Anderson Canc Ctr, Dept Stem Cell Transplantat & Cellular Therapy, Unit 81, Houston, TX 77030 USA
[2] Ohio State Univ, Dept Pediat, Columbus, OH 43210 USA
[3] Columbus Childrens Res Inst, Ctr Childhood Canc, Columbus, OH USA
来源：
INTERNATIONAL JOURNAL OF HEMATOLOGY | 2007年 / 86卷 / 01期
关键词：
mesenchymal stem cells; tumor microenvironment; stroma; vascular network; gene therapy;
D O I：
10.1532/IJH97.06230
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
Recent evidence suggests that mesenchymal stem cells (MSC) selectively home to tumors, where they contribute to the formation of tumor-associated stroma. This effect can be opposed by genetically modifying MSC to produce high levels of anticancer agents that blunt tumor growth kinetics and inhibit the growth of tumors in situ. In this review article, we describe the biological properties of MSC within the tumor microenvironment and discuss the potential use of MSC and other bone marrow-derived cell populations as delivery vehicles for antitumor proteins.
引用
收藏
页码：8 / 16
页数：9
相关论文
共 50 条
  • [31] RETRACTED: Mesenchymal Stem/Stromal Cell-Based Delivery: A Rapidly Evolving Strategy for Cancer Therapy (Retracted Article)
    Hassanzadeh, Ali
    Altajer, Amjad Hussein
    Rahman, Heshu Sulaiman
    Saleh, Marwan Mahmood
    Bokov, Dmitry O.
    Abdelbasset, Walid Kamal
    Marofi, Faroogh
    Zamani, Majid
    Yaghoubi, Yoda
    Yazdanifar, Mahboubeh
    Pathak, Yashwant
    Chartrand, Max Stanley
    Jarahian, Mostafa
    FRONTIERS IN CELL AND DEVELOPMENTAL BIOLOGY, 2021, 9
  • [32] Exosomal MicroRNAs Mediating Crosstalk Between Cancer Cells With Cancer-Associated Fibroblasts and Tumor-Associated Macrophages in the Tumor Microenvironment
    Su, Tong
    Zhang, Panpan
    Zhao, Fujun
    Zhang, Shu
    FRONTIERS IN ONCOLOGY, 2021, 11
  • [33] Stem cell-based and mesenchymal stem cell derivatives for coronavirus treatment
    Rafiee, Zeinab
    Nejaddehbashi, Fereshteh
    Nasrolahi, Ava
    Moghadam, Fatemeh Khademi
    BIOTECHNOLOGY AND APPLIED BIOCHEMISTRY, 2022, 69 (05) : 1942 - 1965
  • [34] Interactions Between Mesenchymal Stem Cells and Microorganisms: Unraveling the Paradox for Enhanced Mesenchymal Stem Cell-Based Therapy
    Kord-Parijaee, Ensiyeh
    Ferdosi-Shahandashti, Elaheh
    Hafezi, Nasim
    TISSUE ENGINEERING PART B-REVIEWS, 2025,
  • [35] Mesenchymal stem cells as therapeutics and vehicles for gene and drug delivery
    Porada, Christopher D.
    Almeida-Porada, Graca
    ADVANCED DRUG DELIVERY REVIEWS, 2010, 62 (12) : 1156 - 1166
  • [36] Fibroblast activation protein regulates tumor-associated fibroblasts and epithelial ovarian cancer cells
    Lai, Dongmei
    Ma, Li
    Wang, Fangyuan
    INTERNATIONAL JOURNAL OF ONCOLOGY, 2012, 41 (02) : 541 - 550
  • [37] Controversial issue: Is it safe to employ mesenchymal stem cells in cell-based therapies?
    Lepperdinger, Guenter
    Brunauer, Regina
    Jamnig, Angelika
    Laschober, Gerhard
    Kassem, Moustapha
    EXPERIMENTAL GERONTOLOGY, 2008, 43 (11) : 1018 - 1023
  • [38] Exosome-based miRNA delivery: Transforming cancer treatment with mesenchymal stem cells
    Balaraman, Ashok Kumar
    Babu, M. Arockia
    Afzal, Muhammad
    Sanghvi, Gaurav
    Rekha, M. M.
    Gupta, Sofia
    Rana, Mohit
    Ali, Haider
    Goyal, Kavita
    Subramaniyan, Vetriselvan
    Wong, Ling Shing
    Kumarasamy, Vinoth
    REGENERATIVE THERAPY, 2025, 28 : 558 - 572
  • [39] Human mesenchymal stem cells-like cells as cellular vehicles for delivery of immunotoxin in vitro
    Hu, Chang-chen
    Ke, Yi-quan
    Sun, Xin-lin
    Jiang, Xiao-dan
    Xu, Ru-xiang
    Lv, Jun
    Wang, Yu-sheng
    Cai, Ying-qian
    Qin, Ling-sha
    Zou, Yu-xi
    BIOTECHNOLOGY LETTERS, 2009, 31 (02) : 181 - 189
  • [40] Human mesenchymal stem cells-like cells as cellular vehicles for delivery of immunotoxin in vitro
    Chang-chen Hu
    Yi-quan Ke
    Xin-lin Sun
    Xiao-dan Jiang
    Ru-xiang Xu
    Jun Lv
    Yu-sheng Wang
    Ying-qian Cai
    Ling-sha Qin
    Yu-xi Zou
    Biotechnology Letters, 2009, 31 : 181 - 189
12345